http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2522908-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8da17385ee93e123768758a8319ef49d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_241467b268ac53e71c92deb11ee9c1c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbd2e74f8439dc1e067ffa76d7245687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13657da69cce9787274f87f54a1d840c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfae18b9f8f6eccd3dac7dc9013bfdec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d201a43ac4849529a1158a2fc31be1f |
| publicationDate | 2014-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2522908-C1 |
| titleOfInvention | Method for assessing risk of developing cervical cancer formation in females with human papillomavirus infection |
| abstract | FIELD: medicine. n SUBSTANCE: cervical biopsy material tissues taken by colposcopic biopsy are examined for typing a human papillomavirus (HPV), apoptosis values (sFAS, TRAIL), genetic characteristics of expression of the genes regulating apoptosis processes, as well as radical formation processes (pyeloperoxidase activity, nitrate-nitrite levels, total antioxidant tissue capacity by the Fenton-type reaction). A summing risk factor of developing cervical cancer formation is calculated by formula. If the summing risk factor K is less than 3, then a low risk of cancer formation is predicted; if K is 3 or more, the risk of cancer formation is considered to be high. n EFFECT: applicability of the given method before the pathological processes are formed in tissues that let doctors prescribe a preventive course and prevent developing cervical cancer if having a predisposition observed or the risk factors detected, applicability of the given method with a diagnosed cervical pathology for the purpose of predicting the disease and monitoring of the efficacy of the conducted therapy. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022261132-A1 |
| priorityDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.